Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity stlouisstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stlouisstar.com Daily Mail and Mail on Sunday newspapers.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new.